Farley J. Abad

Array ( [id] => 5827057 [patent_doc_number] => 20060062805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)' [patent_app_type] => utility [patent_app_number] => 11/167831 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 109 [patent_no_of_words] => 36004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062805.pdf [firstpage_image] =>[orig_patent_app_number] => 11167831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710398 [patent_doc_number] => 20060051743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/166004 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 35776 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051743.pdf [firstpage_image] =>[orig_patent_app_number] => 11166004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435476 [patent_doc_number] => 20090170063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Hcv rna having novel sequence' [patent_app_type] => utility [patent_app_number] => 11/630374 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14854 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170063.pdf [firstpage_image] =>[orig_patent_app_number] => 11630374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225554 [patent_doc_number] => 20050255124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'HCV E1E2 vaccine compositions' [patent_app_type] => utility [patent_app_number] => 11/154324 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17830 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255124.pdf [firstpage_image] =>[orig_patent_app_number] => 11154324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793458 [patent_doc_number] => 20060014139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Five-Helix protein' [patent_app_type] => utility [patent_app_number] => 11/151598 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9155 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014139.pdf [firstpage_image] =>[orig_patent_app_number] => 11151598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045501 [patent_doc_number] => 20050250096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Microorganism detection using bacteriophage amplification' [patent_app_type] => utility [patent_app_number] => 11/147800 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12729 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250096.pdf [firstpage_image] =>[orig_patent_app_number] => 11147800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7018768 [patent_doc_number] => 20050220787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Naturally occuring IgM antibodies that bind to lymphocytes' [patent_app_type] => utility [patent_app_number] => 11/139566 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17410 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220787.pdf [firstpage_image] =>[orig_patent_app_number] => 11139566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608412 [patent_doc_number] => 20060269928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Compositions, methods and apparatus for supercritical fluid virus inactivation' [patent_app_type] => utility [patent_app_number] => 11/139836 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7976 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269928.pdf [firstpage_image] =>[orig_patent_app_number] => 11139836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867486 [patent_doc_number] => 07364738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Monoclonal antibodies to the CLFA protein and method of use in treating infections' [patent_app_type] => utility [patent_app_number] => 11/136559 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15626 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364738.pdf [firstpage_image] =>[orig_patent_app_number] => 11136559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056017 [patent_doc_number] => 20050277192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Hepatitis C virus nonstructural protein 4A (NS4A) is an enhancer element' [patent_app_type] => utility [patent_app_number] => 11/137220 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13289 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277192.pdf [firstpage_image] =>[orig_patent_app_number] => 11137220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743094 [patent_doc_number] => 20060088819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Truncated hepatitis C virus NS5 domain and fusion proteins comprising same' [patent_app_type] => utility [patent_app_number] => 11/131901 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22539 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088819.pdf [firstpage_image] =>[orig_patent_app_number] => 11131901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813324 [patent_doc_number] => 20080193955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Kit and Method for the Detection of Anti-Hepatitis C Virus (Hcv) Antibodies' [patent_app_type] => utility [patent_app_number] => 11/883499 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9832 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193955.pdf [firstpage_image] =>[orig_patent_app_number] => 11883499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168099 [patent_doc_number] => 20050201946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Intranasal influenza virus vaccine' [patent_app_type] => utility [patent_app_number] => 11/119994 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201946.pdf [firstpage_image] =>[orig_patent_app_number] => 11119994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219261 [patent_doc_number] => 20050260568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Hepatitis C virus assays' [patent_app_type] => utility [patent_app_number] => 11/119330 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7510 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260568.pdf [firstpage_image] =>[orig_patent_app_number] => 11119330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019997 [patent_doc_number] => 20050222016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Nucleoside analogs in combination therapy of herpes simplex infections' [patent_app_type] => utility [patent_app_number] => 11/105842 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2098 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222016.pdf [firstpage_image] =>[orig_patent_app_number] => 11105842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285498 [patent_doc_number] => 07550425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Diuretic peptide conjugates' [patent_app_type] => utility [patent_app_number] => 11/102564 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 22472 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550425.pdf [firstpage_image] =>[orig_patent_app_number] => 11102564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545891 [patent_doc_number] => 20090155768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Reporter plasmid phage packaging system for detection of bacteria' [patent_app_type] => utility [patent_app_number] => 11/547587 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12185 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155768.pdf [firstpage_image] =>[orig_patent_app_number] => 11547587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 277866 [patent_doc_number] => 07556940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Assembly of wild-type and chimeric influenza virus-like particles (VLPs)' [patent_app_type] => utility [patent_app_number] => 11/091309 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 14355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/556/07556940.pdf [firstpage_image] =>[orig_patent_app_number] => 11091309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019277 [patent_doc_number] => 20050221296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Hepatitis-C virus type 4, 5 and 6' [patent_app_type] => utility [patent_app_number] => 11/090952 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12061 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221296.pdf [firstpage_image] =>[orig_patent_app_number] => 11090952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7193198 [patent_doc_number] => 20050163797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Pharmaceutical composition comprising an antigen' [patent_app_type] => utility [patent_app_number] => 11/082595 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4140 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163797.pdf [firstpage_image] =>[orig_patent_app_number] => 11082595 [rel_patent_id] =>[rel_patent_doc_number] =>)